NG-MAST | Minimum inhibitory concentration | penAalteration | mtrRalteration | PorB1b (penBalteration) | |||
---|---|---|---|---|---|---|---|
 | Cefixime | Ceftriaxone | A501 alteration (penAallele [[16]]) | A-deletion in promoter region | MtrR coding region | G101 | A102 |
ST4787 (n = 1) | 0.25 | 0.25 | T (XVIII) | Yes | A39T | K | D |
ST4787 (n = 2) | 0.125 | 0.25 | T (XVIII) | Yes | A39T | K | D |
ST4787 (n = 1) | 0.125 | 0.125 | V (A501 New**) | Yes | H105Y | K | D |
ST4787 (n = 3) | 0.064 | 0.125 | T (XVIII) | Yes | A39T | K | D |
ST4787 (n = 1) | 0.032 | 0.125 | T (XVIII) | Yes | A39T | K | D |
ST7159 (n = 2) | 0.064 | 0.125/0.25 | T (XVIII) | Yes | D79N T86A H105Y | K | D |
ST4676 (n = 1) | 0.125 | 0.25 | T (XVIII) | Yes | H105Y | K | G |
3 STsa (n = 4) | 0.125 | 0.125 | T (XVIII) | Yes | A39T | K/Db | D/Gb |
12 STs (n = 15) | 0.064 | 0.125 | T/V/WTc | Yes | A39T G45D H105Yd | K/D/Te | D/G/WTe |